探索分泌脂酶a2通过激活巨细胞来调节淋巴内皮细胞功能障碍的分子机制
Zimin Zhao1, Peilin Li1, Zhong Liu1
1Department of Lymphatic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital; Clinical Center for Lymphatic Disorders, CMU, China.
International journal of biological macromolecules
|December 21, 2024
概括
分泌脂酶A2 (sPLA2) 在淋巴结胀中具有双重作用,影响淋巴内皮细胞 (LEC). 平衡sPLA2水平是维持淋巴血管健康的关键,并为淋巴水提供了新的治疗点.
科学领域:
- 生物医学科学 生物医学科学
- 淋巴细胞生物学 淋巴细胞生物学
- 炎症研究 炎症研究
背景情况:
- 淋巴水是一种慢性疾病,其特点是淋巴系统功能障碍.
- 分泌脂酶A2 (sPLA2) 参与炎症过程,但其在淋巴的具体作用尚不清楚.
- 淋巴内皮细胞 (LEC) 的健康对于淋巴液排水至关重要.
研究的目的:
- 调查sPLA2在淋巴的双重作用.
- 阐明sPLA2对人类LEC (HLEC) 功能的影响.
- 为了确定sPLA2通路内的潜在的治疗点,用于淋巴管理.
主要方法:
- 对HLECs的转录基因分析.
- 涉及HLEC和巨细胞的共同培养实验.
- 评估sPLA2对HLEC活力和功能的影响.
- 对sPLA2/PLA2R轴和阿拉基酸 (AA) 代谢的分析.
主要成果:
- sPLA2对HLEC具有双重影响,低水平具有保护性,高水平具有有害性.
- 巨细胞激活调解了sPLA2对HLECs的影响.
- 功能失调的sPLA2活性和改变的阿拉基酸代谢与淋巴瘤病理学有关.
- sPLA2/PLA2R轴在淋巴结胀中起着重要作用.
结论:
- sPLA2在淋巴瘤病原发生过程中具有复杂的,剂量依赖的作用.
- 保持平衡的sPLA2活性对于HLEC完整性和淋巴功能至关重要.
- 针对sPLA2及其下游通路,为淋巴瘤提供了一个有希望的治疗策略.
相关概念视频
IP3/DAG Signaling Pathway
11.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K
Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K


